Ethical, Legal, and Social Implications of Personalized Genomic Medicine Research: Current Literature and Suggestions for the Future

Purpose: This review identifies the prominent topics in the literature pertaining to the ethical, legal, and social issues (ELSI) raised by research investigating personalized genomic medicine (PGM). Methods: The abstracts of 953 articles extracted from scholarly databases and published during a 5-y...

Description complète

Enregistré dans:  
Détails bibliographiques
Auteurs: Callier, Shawneequa L. (Auteur) ; Abudu, Rachel (Auteur) ; Caga‐Anan, Charlisse (Auteur) ; Mehlman, Maxwell J. (Auteur) ; Neuhauser, Duncan (Auteur) ; Singer, Mendel E. (Auteur) ; Wiesner, Georgia L. (Auteur)
Type de support: Électronique Article
Langue:Anglais
Vérifier la disponibilité: HBZ Gateway
Journals Online & Print:
En cours de chargement...
Fernleihe:Fernleihe für die Fachinformationsdienste
Publié: Wiley-Blackwell [2016]
Dans: Bioethics
Année: 2016, Volume: 30, Numéro: 9, Pages: 698-705
RelBib Classification:NCH Éthique médicale
TK Époque contemporaine
Sujets non-standardisés:B Health Disparities
B Bioethics
B precision medicine
B genomic research
B ELSI
B personalized medicine
Accès en ligne: Volltext (Verlag)
Volltext (doi)
Description
Résumé:Purpose: This review identifies the prominent topics in the literature pertaining to the ethical, legal, and social issues (ELSI) raised by research investigating personalized genomic medicine (PGM). Methods: The abstracts of 953 articles extracted from scholarly databases and published during a 5-year period (2008-2012) were reviewed. A total of 299 articles met our research criteria and were organized thematically to assess the representation of ELSI issues for stakeholders, health specialties, journals, and empirical studies. Results: ELSI analyses were published in both scientific and ethics journals. Investigational research comprised 45% of the literature reviewed (135 articles) and the remaining 55% (164 articles) comprised normative analyses. Traditional ELSI concerns dominated the discourse including discussions about disclosure of research results. In fact, there was a dramatic increase in the number of articles focused on the disclosure of research results and incidental findings to research participants. Few papers focused on particular disorders, the use of racial categories in research, international communities, or special populations (e.g., adolescents, elderly patients, or ethnic groups). Conclusion: Considering that strategies in personalized medicine increasingly target individuals’ unique health conditions, environments, and ancestries, further analysis is needed on how ELSI scholarship can better serve the increasingly global, interdisciplinary, and diverse PGM research community.
ISSN:1467-8519
Contient:Enthalten in: Bioethics
Persistent identifiers:DOI: 10.1111/bioe.12285